Details for 2013166632

Up to date per 02.04.2026

Actions

Title / Product Name

(+) -1,4-Dihydro-7- [(3s, 4s) -3-methoxy-4- (methylamino) -1-pyrrolidinyl] -4-oxo-1- (2-thiazolyl) -1,8-naphthyridin-3-Carbonsäure zur Verwendung bei der Behandlung von einem myelodysplatisches Syndrom

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2013166632

EP Publication Number

2649997

E-Number

1090907

Language

PCT Number

Publication Date

16.10.2013 A

23.01.2019 B1

Registration Date

23.01.2019

AT Publication Date

15.02.2019

Application Date

10.12.2008

Registration Number

Priorities

10.12.2007

7229 P

IPC

A61K 31/4375 20060101AFI20180723BHEP

Maximum Duration of Protection

10.12.2028

Owner

Sunesis Pharmaceuticals, Inc.395 Oyster Point Boulevard, Suite 400 South San Francisco, CA 94080US

Representative

No representatives present

Inventor

Michelson, Glenn98 Midcrest Way San Francisco, CA California 94131US